1 Min Read
May 1 (Reuters) - Prescient Therapeutics Ltd:
* FDA grants orphan drug designation for PTX-200 in acute myeloid leukemia Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.